F*CK CANCER
10 min readFrom Chapter 10 — The Ketogenic Diet and Cancer: Starving the Enemy of the book

Ketogenic Diet and Cancer: A Complete Guide to Metabolic Therapy

How ketogenic metabolism pressures tumors, what the Glucose Ketone Index measures, and how to do it safely. Chapter 10 of F*CK CANCER, in depth.

ketogenic diet cancermetabolic therapyGlucose Ketone Indexintermittent fasting

Chapter 1 of the book explains why cancer's broken metabolism is a target. Chapter 10 is the how — the complete practical guide to the ketogenic approach as a metabolic therapy, from the biochemistry to the blood meter. If the idea of fighting cancer with food sounds too simple to be serious, this chapter exists to change your mind with data.

The strategy in one sentence

Cancer cells ferment sugar because their mitochondria are broken; healthy cells can burn fat and ketones instead; therefore, a diet that removes sugar and provides ketones selectively pressures the tumor while feeding the patient. That is the entire thesis — and Chapter 10 spends its pages making it precise.

What the ketogenic protocol actually looks like

The chapter is a working guide, not a theory paper:

  • The macronutrient architecture — very low carbohydrate, moderate protein, high healthy fat, and why each lever matters. Protein is moderated deliberately: excess protein can be converted to glucose, and some amino acids feed tumor growth pathways.
  • Intermittent Fasting as a partner — fasting windows deepen ketosis and activate autophagy, the cellular cleanup program that many cancer cells cannot use properly.
  • Food quality — the chapter distinguishes therapeutic ketogenic eating from the bacon-and-butter caricature: the fats, the vegetables, and the foods that must go.

The number that makes it a treatment: the GKI

What turns a diet into a measurable therapy is the Glucose Ketone Index — a single number calculated from blood glucose and blood ketone readings. Lower values indicate deeper therapeutic ketosis: the zone where metabolic pressure on tumor cells is greatest. With an inexpensive meter, a patient can track, daily, the variable this strategy depends on — the same way a blood-pressure cuff turns hypertension management into something concrete. The chapter covers the targets practitioners use and how to interpret the readings.

The honest boundaries

Chapter 10 is equally clear about what the ketogenic approach is not. It is not a standalone cure — some tumors find workarounds, scavenging amino acids like glutamine. It is not appropriate for everyone — certain cancer types, medications, and conditions (including some liver and pancreatic situations) change the calculus entirely. And it must never be run alongside treatment without the oncology team's knowledge, because it can interact with therapy in both directions.

Its rational role is the one the book's whole strategy is built on: a foundation that weakens the tumor's fuel supply and growth signals so that every other therapy — conventional or integrative — fights a weaker opponent.

You cannot out-eat a tumor. But you can change what the tumor is allowed to eat.

The full protocol — the food lists, the GKI targets, the fasting integration, the safety boundaries — is Chapter 10 of the book, and the evidence behind each component is free in the Cure Finder.

Educational content, not medical advice. Dietary changes during cancer treatment can interact with therapies — bring this to your oncology team first.

Frequently asked questions

What is the glucose ketone index?

The glucose ketone index, or GKI, is a single number tracking the balance between blood glucose and ketones. Therapeutic ketosis in cancer research typically targets a GKI near or below 1.0, measured with an ordinary home meter.

What does a therapeutic ketogenic diet look like?

Therapeutic keto is stricter than weight-loss keto — often a 4:1 or 3:1 ratio of fat to protein plus carbohydrate, built around fatty fish, eggs, avocado, olive oil, and leafy greens, with precise tracking.

Who should not try a ketogenic diet for cancer?

Patients with cachexia or uncontrolled weight loss, certain metabolic disorders, or those taking specific drugs like SGLT2 inhibitors face real risks. Therapeutic keto requires medical supervision, not casual experimentation.